Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) have recently emerged as issues of concern among critical care physicians 1, 2 . Consensus definitions and guidelines for the measurement of intra-abdominal pressure (IAP) have been developed 1, 2 and more studies performed to define its incidence, risk factors and outcome associations [3] [4] [5] [6] [7] [8] .
Epidemiological studies have so far reported a highly variable incidence of IAH in critically ill patients, with values ranging from 31 to 59% [3] [4] [5] [6] [7] [8] . They have also reported that IAH and ACS are significantly associated with morbidity and mortality 3-12 . This variation in incidence and severity may be explained by casemix (medical vs surgical vs trauma patients) but also by the use of different definitions, inconsistent techniques of IAP measurement and the application of a variable zero reference point.
In response to the variable definitions used in the literature and the above technical concerns, a group of experts recently developed consensus definitions and guidelines for the measurement of IAP and the diagnosis and treatment of IAH and ACS. The aim of these guidelines is to increase the comparability of observational studies, facilitate the design of future clinical trials and improve patient care 1, 2 . However, to our knowledge, no studies have yet used such consensus guidelines to more accurately assess the incidence, risk factors and outcome associations of IAH in a combined cohort of medical and surgical critically ill patients. Accordingly, we performed a prospective observational study and applied recently published consensus criteria to measure and describe Original Papers SUMMARY Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are significantly associated with morbidity and mortality. We performed a prospective observational study and applied recently published consensus criteria to measure and describe the incidence of IAH and ACS, identify risk factors for their development and define their association with outcomes. We studied 100 consecutive patients admitted to our general intensive care unit. We recorded relevant demographic, clinical data and maximal (max) and mean intra-abdominal pressure (IAP). We measured and defined IAH and ACS using consensus guidelines. Of our study patients, 42% (by IAPmax) and 38% (by IAPmean) had IAH. Patients with IAH had greater mean body mass index (30.4±9.6 vs 25.4±5.6 kg/m 2 , P=0.005), Acute Physiology and Chronic Health Evaluation III score (78.2±28.5 vs 65.5±29.2, P=0.03) and central venous pressure (12. 8±4.8 vs 9.2±3.5 mmHg, P <0.001), lower abdominal perfusion pressure (67.6±13.5 vs 79.3±17.3 mmHg, P <0.001) and lower filtration gradient (51.2±14.8 vs 71.6±17.7 mmHg; P <0.001). Risk factors associated with IAH were body mass index ≥30 (P <0.001), higher central venous pressure (P <0.001), presence of abdominal infection (P=0.005) and presence of sepsis on admission (P=0.035). Abdominal compartment syndrome developed in 4% of patients. IAP was not associated with an increased risk of mortality after adjusting for other confounders. We conclude that, in a general population of critically ill patients, using consensus guidelines, IAH was common and significantly associated with obesity and sepsis on admission. In a minority of patients, IAH was associated with abdominal compartment syndrome. In this cohort IAH was not associated with an increased risk of mortality.
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MATERIALS AND METHODS
The Hospital Human Research Ethics committee approved the study protocol and waived the need for informed consent.
We studied 100 consecutive patients admitted to our general intensive care unit (ICU) between 1 August 2009 and 28 February 2010. We included patients expected to remain in the ICU for more than 24 hours, older than 18 years of age, able to lie supine if necessary and with a urinary catheter in situ. We excluded patients unable to remain in a supine position, pregnant women, those with confirmed urinary tract infection, bladder surgery or presence of a renal transplant. All data were collected prospectively.
Data collection
On admission, we obtained information on age, gender, past medical history (liver disease, hypertension, renal disease and diabetes mellitus), main diagnosis, medical, surgical or traumarelated admission, presence of sepsis, use of renal replacement therapy and recent abdominal surgery. We also collected the patients' Acute Physiology and Chronic Health Evaluation (APACHE) III score, APACHE II score and Simplified Acute Physiology Score (SAPS) II, and followed up all patients to calculate length of stay in the ICU and to measure hospital mortality.
In addition, we assessed all patients for the following possible risk factors for IAH/ACS: body mass index (BMI), severity of acute renal failure defined using the Risk Injury Failure Loss End-Stage Kidney Disease (RIFLE) criteria 9 , abdominal infection and/or liver dysfunction (hepatic failure, pancreatitis, abdominal abscess and ascites), fluid balance over 24 hours, mechanical ventilation with positive end-expiratory pressure, mean airway pressure and acid-base balance (base excess and plasma lactate).
Protocol for the measurement of intra-abdominal pressure
We measured IAP according to the guideline of the World Society of Abdominal Compartment Syndrome (WSACS). We placed all patients in the supine position, lying flat. We measured IAP (in millimetres of mercury) from the urine drainage line via the needle-free sampling port (Kendal Precision™ 400, Urine meter, Tyco Healthcare, Gosport, UK). We attached 30 cm sterile pressure tubing (ITL Healthcare Pty, Chelsea, Vic.) to the sampling port of the urine meter line for each measurement. We used a three-way stopcock (BD Connecta™, Helsingborg, Sweden) and an intravenous infusion set (ICU Medical Inc, San Clemente, CA, USA) to connect the sampling port of the urine meter line to a pressure transducer (ITL Healthcare Pty, Chelsea, Vic.). The pressure recorded by the transducer was transmitted to the central venous pressure (CVP) grid on the bedside monitor after removing the CVP cable momentarily for the measurement (Intellivue MP70, Philips Medical Systems, Suresnes, France). We zeroed the pressure transducer at the level of mid-axillary line at the iliac crest. After double clamping the urine meter tubing leading to the urine collection bag, we drained 25 ml of saline from a measurement burette into the bladder, by gravity. When the patient was stable and supine for at least one minute, we recorded his/her IAP at end of expiration. The instruments and technique for measurement IAP are shown in the electronic data file (see Appendix in the website version). We repeated the procedure after three to five minutes, and we used the mean of the two measurements as the IAP value for that episode. We did not measure IAP on day 1. We measured IAP a maximum of three times from day 2 to day 4 after ICU admission. We recorded or calculated mean arterial pressure (MAP), CVP, abdominal perfusion pressure (APP) and filtration gradient (FG) with every measurement of IAP.
We calculated APP according to the consensus formula: APP=MAP-IAP 1 . We calculated FG according to the consensus formula: FG=MAP-2×IAP 1 .
We calculated fluid balance (total input-total output) each day of IAP measurement.
Definitions
We defined IAH as a sustained elevation in IAP of 12 mmHg. We defined ACS as a sustained elevation of IAP 20 mmHg associated with new organ dysfunction according to the consensus criteria of the WSACS 1,2 . We also defined APP and FG according to the same criteria 1 .
We defined BMI as the person's weight (in kilograms) divided by the square of his or her height (in metres). We classified a person with a BMI ≥25 as overweight and a person with a BMI ≥30 as obese 13 .
We classified acute kidney injury according to the maximum RIFLE class criteria (class R, class I or class F) reached during their ICU stay 14 . The RIFLE class was determined based on the worst of estimated glomerular filtration rate or urine output criteria and their change from baseline 14 .
We used APACHE III 15 , APACHE II 16 and SAPS II 17 methodology in order to accurately predict hospital mortality for critically ill patients. We defined sepsis according to the criteria of the Society of Critical Care Medicine 18 . We defined the following risk factors: 1. Abdominal surgery as any surgery that required incision of the abdominal wall.
Abdominal infection as radiologically (intra-
abdominal collection with evidence of systemic inflammation) and/or microbiologically confirmed infection of the peritoneal cavity. 3. Acidaemia as an arterial pH below 7.2 and metabolic acidosis as base excess below -2.0 mEq/l. 4. Liver dysfunction as cirrhosis or other liver failure with ascites. 5. Mechanical ventilation as use of invasive positive pressure ventilation through an endotracheal tube or a tracheostomy tube with or without positive end-expiratory pressure. 6. Fluid balance over 24 hours as total input -total output each day of IAP measurement.
Statistical analysis
We present continuous variables as mean±SD, median with interquartile range and categorical variables as percentages. We compared continuous variables with Student's t-test when normally distributed and the Mann-Whitney test when nonnormally distributed. We used the chi-square test or Fisher's exact test to compare categorical variables as appropriate. We performed multiple logistic regression analysis, with IAH as dependent variables to define risk factors for its presence. Baseline variables associated with IAH in univariate analysis (using P <0.1) were incorporated in the initial model together with variables physiologically likely to be associated with IAH. A model was then constructed by backward elimination of nonsignificant predictor variables. Odds ratios with 95% confidence intervals were calculated. Similarly, multiple linear regression analysis was performed using IAPmax as the dependent variable. Simple linear regression analysis with Pearson r 2 values was also performed between significant continuous variables in the multiple analysis and IAPmax. All P values were two-tailed, and we considered a P ≤0.05 statistically significant. We performed our statistical analysis with SPSS (version 16.0, SPSS, Chicago, IL, USA) additional multivariate analysis was performed using R; a language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
During the study period, we performed 206 measurements in 100 consecutive patients. The diagnostic grouping for the study patients was medical, surgical or trauma-related in 52, 37 and 11% respectively. The incidence of IAH was 42% using IAPmax and 38% using IAPmean (33.3% in those patients who received one measurement). The mean of IAPmax and IAPmean in the 100 patients were 11.3±5.5 and 10.2±5.2 mmHg, respectively (10.3±4.9 mmHg in those patients receiving one measurement). Figure 1 shows the distribution of grades of intra-abdominal pressure (IAPmax). found no differences (P=0.547) between patients who had one, two or more measurements (Figure 2 ). In patients with multiple measurements the mean difference between each measurement and the next was 1 mmHg. We performed multivariable logistic regression analysis to assess clinical and demographic factors associated with development of IAH (as defined by IAPmax). Age, gender, APACHE III score, abdominal surgery, presence of mechanical ventilation and 24 hour fluid balance were nonsignificant and eliminated from the model. Obesity (BMI ≥30), presence of sepsis on admission, presence of abdominal infection and central venous pressure were retained in the final model (Table 2A ) and were all associated with increased (Table 2B ). In simple linear regression analysis both BMI and CVP correlated with IAPmax ( Figure 3A and B) . Five patients had high IAP (IAPmax 20). Of these five patients, four developed ACS, but all survived. Among these, one patient had primary, two patients had secondary and one had recurrent ACS (Table 3) . Table 4 shows the characteristics of survivors and non-survivors. Sixteen patients (16%) died in hospital. Compared with survivors, non-survivors had significantly higher APACHE III scores (P <0.001), lower base excess (P=0.04) and more acute kidney injury (P=0.05). However, IAP was not different between the two groups. Multivariable analysis for ICU and hospital mortality found that the only significant predictors of mortality were APACHE II, III or SAPS II scores.
DISCUSSION

Statement of key findings
In our study of general ICU patients, using consensus criteria and following consensus guidelines for measurement, the incidence of IAH was approximately 40%. Only five patients had a high IAP and only four patients developed ACS. One patient with a high IAP had a BMI of 73 without evidence of organ failure. There was a correlation between BMI and IAP and between CVP and IAP. We identified several risk factors for IAH, of which obesity was the strongest, but found that IAH itself was not associated with an increased risk of mortality and that IAP among survivors was similar to that of non-survivors.
Comparison with previous studies
The incidence of IAH in our study was similar to previous reports (31 to 59%) [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, compared with a mortality of 27.5 3 , 43 4 , 20.4 6 , 42.4 11 and 33.3% 12 , as reported in other studies, our mortality was relatively low. This difference cannot be fully explained by illness severity because our mean APACHE II scores (19.4) and SAPS scores (38.1) appeared equivalent to those seen in other studies of IAH, which reported APACHE II scores of 17.4 3 or 19 4 , 30 9 and a SAPS II score of 39.1 3 . Our mortality was also lower than that predicted from APACHE III score and co-morbidities (16% vs mean predicted mortality 32%), however we recruited only patients who were alive and not moribund 24 hours after ICU admission, so a number of patients who died early in ICU stay would have been excluded and the standard error in predicted mortality was large. Only four patients developed ACS (4%), a low incidence compared to previous reports of 12 4 study which reported an incidence of 4.2% 3 . Some of these differences may reflect other factors such as BMI or fluid therapy or casemix.
We found that a higher BMI had an independent association with IAH and that BMI correlated with IAP. This observation is in agreement with the view that the baseline value of 'normal' IAP in obese patients can be significantly higher than in patients with a BMI below 25 19, 20 and previous knowledge that obesity is an independent risk factor for IAH 1,3-5 . The fact that obese patients normally have a higher IAP makes it difficult to know if an elevated IAP in obese patients is acute, or chronic, or acute on chronic. It also makes it difficult to know whether it has clinical implications. In this regard, one of our patients, with the second highest IAP had a BMI of 76 but did not have evidence of ACS despite an IAP of 26 mmHg. Five other studies have reported the mean BMI in their ICU population 3, 5, [9] [10] [11] with values between 23 and 27 respectively. Thus, given that our BMI is the highest reported so far in such studies, differences in BMI cannot explain the lower incidence of severe IAH. However, fluid management might have influenced our findings.
Massive fluid resuscitation is considered a major contributor to the development of IAH/ACS in critically ill patients [3] [4] [5] 7, [21] [22] [23] . Kula et al 23 reported that negative fluid balance may decrease IAP. Our patients had a mean negative fluid balance of >-300 ml/day, and on univariate analysis no association between fluid balance and IAP was evident in our population, however on multiple linear regression a non-significant trend toward increasing IAP with positive fluid balance was evident (P=0.06). We did find a strong independent association between higher CVP and IAP. This suggests fluid overload, as evidenced by raised CVP, may be associated with development of IAH, however as IAH will itself raise the CVP by compressing venous reservoirs the direction of causality underlying this association is difficult to assess. Other studies linking IAH with fluid therapy, reported either a markedly positive fluid balance 4, 7 or an association with aggressive fluid resuscitation 3, 5, 7 . The relatively negative fluid balances in our patients may explain why IAH we observed was generally mild and ACS uncommon. This suggests that, in some patients, the transition from increased IAP to ACS may represent an iatrogenic phenomenon.
Differences in casemix might also explain our findings. Trauma case series predictably have a higher incidence of IAH and ACS. However, our focus was on general ICU patients. Compared to studies of such populations 3, 4, [9] [10] [11] , our patients had a similar age and similar gender distribution. However, the incidence of sepsis was the highest reported in unselected cohorts, while more patients were medical than in other similar studies. The incidence of trauma was between the values of 8.7 to 27% reported by others. Finally, 81% of our patients were mechanically ventilated. Only one other paper reported on this variable with a value of 61%. Whether these differences in casemix are sufficient to explain differences in the incidence of ACS is uncertain.
We found, like others, that sepsis on admission and, in particular abdominal sepsis, was a significant risk factor for IAH [3] [4] [5] [6] . Sepsis has been previously associated with IAH [1] [2] [3] 20 . Such factors are plausible because of their logical association with fluid therapy, oedema and increased abdominal wall tightness secondary to sutures. Similar to other studies, we failed to find an independent association between illness severity and IAH [3] [4] [5] [6] [7] .
The kidney appears to be particularly vulnerable to IAH. Renal perfusion pressure (approximated by APP) and glomerular FG are closely associated with IAP [24] [25] [26] . In our study, FG was decreased by about 20 mmHg with IAH and APP by 12 mmHg. However, serum creatinine levels, RIFLE class and continuous renal replacement therapy use were not increased in patients with IAH. This may have been due to the fact that, even in patients with IAH, APP was preserved to a mean value of close to 70 mmHg in some patients (>40%) by means of vasopressor therapy. In this regard, low APP was in its own right a predictor of acute kidney injury in a previous observation study of IAH in the ICU 27 and a strategy of maintaining APP with vasopressors has been associated with preservation of renal blood flow in animal models of IAH 28 . Consequently, WSACS recommends an APP value of 50 to 60 mmHg in patients with IAH/ACS 2 . Finally, we treated four patients with ACS. We did not perform decompressive procedures in any of these patients. We simply attempted to maintain a negative fluid balance and targeted APP with vasopressor drugs in one patient. None of these patients died. In keeping with such results and some studies 5,7 , we found no independent association between IAP and mortality. Other studies however, have reported such association 3, 4, 6 . This difference may stem from the fact that IAP was only mildly elevated in most of our patients or may relate to limited statistical power.
Significance of study findings
This is one of few studies to date to use consensus criteria and consensus techniques of IAP measurement in ICU patients. By using these criteria in a general population of ICU patients, this study gives a more representative picture of the likely epidemiology of IAH in most general ICUs. This information can be used by clinicians working in a similar environment to estimate the likely incidence, severity and clinical importance of IAH in their patients. By showing the strong impact of BMI on IAP, we highlight the difficulties associated with making a diagnosis of clinically relevant IAH in these patients. In markedly obese patients, our findings invite caution in assuming that an elevated IAP represents an acute phenomenon which requires aggressive treatment. Furthermore, our study suggests that, if a conservative fluid balance is applied and vasopressors used when indicated to maintain APP, renal function can be preserved and, even in the setting of ACS, outcome can be satisfactory without surgical decompression.
Future research
Our study provides the first information on the incidence and outcome of IAH using consensus criteria. Its findings provide information that might help clinicians design and power interventional studies aimed at preventing ACS. Given a 4% incidence of ACS in general ICU patients, an intervention with the ability to reduce its occurrence by a relative 30% decrease would require the randomisation of >5000 patients. If future research aimed instead to develop an effective intervention for established ACS, more epidemiological studies are needed to define its mortality when clinicians opt for a conservative fluid treatment coupled with vasopressor support of APP.
Strengths and limitations
This study has several strengths. It is prospective in design; it included consecutive patients, thus minimising bias; it measured IAP according to consensus guidelines with double measurement separated by several minutes to confirm that the value found was sustained, and used a standardised method by one investigator for all measurements; it defined IAH and ACS also according to consensus criteria; and it studied a general population such as might be seen in most ICUs in developed countries. This study has, however, several limitations. First, it was performed in a single centre. Our findings, therefore, might be not generalisable to other ICUs. However, our ICU has all the characteristics and casemix of most general ICUs in developed countries. Second, we did not measure IAP every six or eight hours each day. Thus, we might have missed episodes of IAH. However, we performed 206 measurements in our patients, making it unlikely that patients with sustained IAH would have been missed. In keeping with this notion, the incidence of IAH in our patients was similar to other studies and repeated measurements, when made, showed little variation (1 mmHg) from each other. These findings suggest that, unless major events take place that can be reasonably expected to alter IAP, repeated measures are unlikely to show clinically relevant or statistically detectable changes and may be both cumbersome and unnecessary. Third, we studied only 100 patients. While this may have limited our power to detect independent associations, we did detect several important independent risk factors for IAH. This makes it likely that any missed independent associations would have been of limited strength. Finally, only four patients met the criteria for ACS, and while these patients had a positive outcome, no definitive conclusions regarding management should be drawn from a small subset within an uncontrolled study.
CONCLUSIONS
This is one of few studies to date to study the epidemiology, risk factors and outcome associations of IAP in a general ICU population using WSACS guidelines. We found that IAH was common but generally mild and that ACS was uncommon. We also found that BMI had a strong effect on IAP and that IAP was not associated with an increased risk of mortality. More studies are needed to understand the contribution of increased IAP to patient outcomes in general ICU patients.
